← 產業報告目錄

Healthcare Information Exchange (HIE) Market by Type (Direct, Query), Mode (Centralized, Decentralized), Setup (Private, Public), Solution (Portal, Platform), Application (Workflow, Interfacing), End User (Hospital, ASC) - Global Forecast to 2031

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-04-29頁數 344報告編號 HIT2265

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The healthcare information exchange (HIE) market is projected to reach USD 3.40 billion by 2031 from USD 2.09 billion in 2026, at a CAGR of 10.3% from 2026 to 2031. This market expansion is primarily driven by the need for seamless exchanges of patient health information within the healthcare environment. As healthcare delivery becomes increasingly fragmented, with patients seeking medical attention from multiple providers, there is a growing demand for coordinated and consistent services. Additionally, regulatory policies, government initiatives, and programs designed to promote interoperability and information exchange have contributed to the adoption of HIE solutions. Notable examples of these initiatives include the MACRA legislation and the Promoting Interoperability program (formerly known as Meaningful Use), which offer incentives for adopting electronic health record (EHR) technologies that incorporate HIE capabilities. However, the market faces challenges due to the lack of standardized data formats and interoperability between incompatible systems. “By solution, the platform-centric HIE solutions segment is expected to witness the highest growth during the forecast period.” The health information exchange (HIE) market is divided into three segments: portal-centric, messaging-centric, and platform-centric. Among these, the platform-centric solutions segment is expected to grow the fastest. This growth is driven by an increasing need for cloud-enabled ecosystems that facilitate data sharing and interoperability among healthcare stakeholders. Platform-centric solutions encompass integrated platforms that combine data exchange, analytics, and applications, enhancing both operational efficiency and decision-making. One example of a company in this space is Veradigm, which offers data platforms that promote interoperability using FHIR standards and enable real-time data exchange among various industry stakeholders. “By application, the web portal development segment held the largest market share in 2025.” The health information exchange market is segmented based on application into web portal development, workflow management, secure messaging, internal interfacing, and other applications. The web portal development segment held the largest market share in 2025 due to its crucial role in providing easy access to patient health data for both medical professionals and patients. Web portals serve as central hubs where users can access, share, and organize their health data, including test results, drug profiles, and other health-related information. A key factor contributing to the success of the web portal development category is its widespread use by hospitals of all sizes and types. This accessibility allows doctors to quickly obtain patient health data from various sources, including electronic health record (EHR) systems, lab data, and imaging systems. “By end user, the healthcare providers segment is expected to register the highest growth in the health information exchange market during the forecast period.” The health information exchange (HIE) market is segmented by end user into three categories: healthcare providers, healthcare payers, and pharmacies. The healthcare providers segment is experiencing the fastest growth due to its vital role in delivering care and managing patient medical records. In the US, healthcare providers are increasingly focusing on implementing HIE solutions to enhance care coordination and ensure regulatory compliance. For example, in June 2023, the prominent healthcare provider, Mayo Clinic, announced a strategic alliance with Microsoft to launch the Azure Health Data Services platform. This platform is equipped with HIE functionality, enabling seamless data exchange across the organization's facilities. “The APAC is estimated to register the highest CAGR during the forecast period.” This report segments the healthcare information exchange (HIE) market into several regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The HIE market in the Asia Pacific (APAC) region is projected to experience the highest compound annual growth rate (CAGR) during the forecast period. This growth is largely due to significant transformations in the APAC healthcare landscape, characterized by increased digitization, urbanization, and higher healthcare spending. As more healthcare organizations adopt technological innovations to enhance their services, the necessity for data exchange and interoperability is becoming more evident. Additionally, government policies and programs aimed at promoting the use of IT solutions and interoperability in the healthcare sector are further driving the HIE market in the APAC region. Countries such as China, Japan, South Korea, and Australia are leading the charge by encouraging the adoption of e-health technologies through the establishment of national health IT strategies and interoperability standards. These initiatives facilitate the exchange of electronic health records (EHRs) and other critical health information among healthcare institutions. Noteworthy examples include China’s Healthy China 2030 initiative and Australia’s My Health Record program. Breakdown of Supply-side Primary Interviews, by Company Type, Designation, and Region: • By Company Type: Tier 1 (40%), Tier 2 (35%), and Tier 3 (25%) • By Designation: C-level Executives (35%), Directors (45%), and Others (20%) • By Region: North America (55%), Europe (20%), Asia Pacific (15%), Latin America (5%), and the Middle East & Africa (5%) List of Companies Profiled in the Report o Epic Systems Corporation (US) o Oracle (US) o InterSystems Corporation (US) o Veradigm LLC (US) o Medical Information Technology, Inc. (US) o Health Catalyst (US) o Chetu Inc. (US) o Meditab (US) o Siemens Healthineers (Germany) o Deloitte (UK) o Dreamsoft4u (US) o NCrypted Technologies. (India) o Glorium Technologies (US) o Daffodil Unthinkable Software Corporation (US) o eClinicalWorks (US) o NXGN Management, LLC (US) o Orion Health (New Zealand) o Kellton (India) o Telstra Health (Australia) o CGI Inc. (Canada) o Excelicare (US) o Octal IT Solution (US) o Andersen (Poland) o SISGAIN (India) o Cleverdev Software (US) o OSP Labs (US) Research Coverage This report analyzes the healthcare information exchange market based on various factors, including type, setup type, implementation model, solution, component, application, end user, and region. It examines the drivers, opportunities, and challenges that influence market growth. Additionally, the report assesses the opportunities and challenges for stakeholders and details the competitive landscape for market leaders. The study also explores micro markets, focusing on their growth trends, prospects, and contributions to the overall health information exchange market. Furthermore, it provides revenue forecasts for the market segments across five major regions. Reasons to Buy the Report This report also includes. • Analysis of key drivers (rising adoption of EHR/EMR solutions, growing focus on patient-centric care delivery, need to curtail escalating healthcare costs, government initiatives and regulations to enhance patient care and safety, and rising investments from government and private institutions), restraints (need for significant investments in infrastructure development and high cost of deployment, lack of true interoperability solutions, and use of outdated legacy systems), opportunities (improving healthcare infrastructure in emerging markets and advancements in software technology for real-time data exchange), and challenges (patient data security and privacy concerns in the healthcare industry, increasing complexity due to lack of consistent data, and shortage of skilled healthcare IT professionals) are contributing the growth of the healthcare information exchange market. • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the healthcare information exchange market. • Market Development: Comprehensive information on the lucrative emerging markets, components, applications, end users, and regions. • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, and investments in the healthcare information exchange market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global healthcare information exchange market.
目錄 Table of Contents
1 INTRODUCTION 29 1.1 STUDY OBJECTIVES 29 1.2 MARKET DEFINITION 29 1.3 STUDY SCOPE 30 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 30 1.3.2 INCLUSIONS & EXCLUSIONS OF STUDY 31 1.3.3 YEARS CONSIDERED 32 1.3.4 CURRENCY CONSIDERED 32 1.4 STAKEHOLDERS 33 1.5 SUMMARY OF CHANGES 33 2 EXECUTIVE SUMMARY 34 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 34 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 35 2.3 DISRUPTIVE TRENDS SHAPING HEALTHCARE INFORMATION EXCHANGE MARKET 36 2.4 HIGH-GROWTH SEGMENTS 37 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 38 3 PREMIUM INSIGHTS 39 3.1 ATTRACTIVE OPPORTUNITIES FOR HEALTHCARE INFORMATION EXCHANGE MARKET 39 3.2 NORTH AMERICA HEALTH INFORMATION EXCHANGE MARKET, BY END USER AND COUNTRY 40 3.3 HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY 41 4 MARKET OVERVIEW 42 4.1 INTRODUCTION 42 4.2 MARKET DYNAMICS 42 4.2.1 DRIVERS 43 4.2.1.1 Rising adoption of EHR/EMR solutions 43 4.2.1.2 Growing focus on patient-centric care delivery 43 4.2.1.3 Need to curtail escalating healthcare costs 44 4.2.1.4 Government initiatives and regulations to enhance patient care & safety 45 4.2.1.5 Rising investments from government & private institutes 46 4.2.2 RESTRAINTS 47 4.2.2.1 Need for significant investments in infrastructure development and high cost of deployment 47 4.2.2.2 Lack of true interoperability solutions 47 4.2.2.3 Use of outdated legacy systems 48   4.2.3 OPPORTUNITIES 49 4.2.3.1 Improving healthcare infrastructure in emerging markets 49 4.2.3.2 Advancements in software technology for real-time data exchange 49 4.2.4 CHALLENGES 51 4.2.4.1 Patient data security and privacy concerns in healthcare industry 51 4.2.4.2 Increasing complexity due to lack of consistent data 52 4.2.4.3 Shortage of skilled healthcare IT professionals 52 4.3 UNMET NEEDS AND WHITE SPACES 53 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 54 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 55 5 INDUSTRY TRENDS 56 5.1 PORTER’S FIVE FORCES ANALYSIS 56 5.1.1 BARGAINING POWER OF SUPPLIERS (MODERATE) 57 5.1.2 BARGAINING POWER OF BUYERS (HIGH) 57 5.1.3 THREAT OF SUBSTITUTES (LOW TO MODERATE) 57 5.1.4 THREAT OF NEW ENTRANTS (MODERATE) 58 5.1.5 INTENSITY OF COMPETITIVE RIVALRY (HIGH) 58 5.2 MACROECONOMIC INDICATORS 58 5.2.1 GDP TRENDS AND FORECAST 58 5.2.2 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY 59 5.3 VALUE CHAIN ANALYSIS 59 5.4 ECOSYSTEM ANALYSIS 61 5.5 PRICING ANALYSIS 64 5.5.1 INDICATIVE PRICING ANALYSIS OF KEY PLAYERS, BY TYPE, 2025 64 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION, 2025 65 5.6 KEY CONFERENCES AND EVENTS, 2026–2027 65 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66 5.8 INVESTMENT AND FUNDING SCENARIO 67 5.9 CASE STUDY ANALYSIS 68 5.9.1 INTEROPERABILITY SOLUTIONS TO LEVERAGE CLINICAL WORKFLOWS 68 5.9.2 SHARING CLINICAL INFORMATION TO SET FOUNDATION OF EFFICIENT AND EFFECTIVE HEALTHCARE DELIVERY 68 5.9.3 SUPPORTING HEALTH INFORMATION EXCHANGE ACCESS 69 5.10 IMPACT OF 2025 US TARIFF 69 5.10.1 KEY TARIFF RATES 70 5.10.2 PRICE IMPACT ANALYSIS 71 5.10.3 IMPACT ON COUNTRY/REGION 71 5.10.3.1 US 71 5.10.3.2 Europe 72 5.10.3.3 Asia Pacific 72   5.10.4 IMPACT ON END-USE INDUSTRY 73 5.10.4.1 Healthcare Providers 73 5.10.4.2 Healthcare Payers 73 5.10.4.3 Pharmacies 73 5.10.4.4 Laboratories 73 6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 74 6.1 KEY TECHNOLOGIES 74 6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 74 6.1.2 BLOCKCHAIN 75 6.2 COMPLEMENTARY TECHNOLOGIES 75 6.2.1 INTERNET OF THINGS 75 6.2.2 DATA ANALYTICS AND BUSINESS INTELLIGENCE TOOLS 75 6.3 ADJACENT TECHNOLOGIES 76 6.3.1 CLOUD COMPUTING 76 6.4 TECHNOLOGY/PRODUCT ROADMAP 76 6.5 PATENT ANALYSIS 77 6.5.1 PATENT PUBLICATION TRENDS FOR THE HEALTHCARE INFORMATION EXCHANGE MARKET 77 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 78 6.6 FUTURE APPLICATIONS 81 6.6.1 AI-DRIVEN PREDICTIVE CARE COORDINATION AND DECISION SUPPORT 82 6.6.2 UNIFIED LONGITUDINAL PATIENT RECORDS AND CONSUMER ACCESS 82 6.6.3 REAL-TIME PUBLIC HEALTH SURVEILLANCE AND EMERGENCY RESPONSE 82 6.6.4 BLOCKCHAIN-ENABLED TRUSTED DATA EXCHANGE 82 6.6.5 VALUE-BASED CARE, PAYER INTEGRATION, AND REVENUE OPTIMIZATION 82 6.6.6 INTEGRATION WITH REMOTE MONITORING, GENOMICS, AND PRECISION MEDICINE 82 6.7 IMPACT OF AI/GEN AI 83 6.7.1 MARKET POTENTIAL OF AI/GEN AI 84 6.7.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION 85 6.7.2.1 AI-Driven Clinical Summarization and Interoperability Intelligence at InterSystems HealthShare 85 6.7.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 86 6.7.3.1 Healthcare data analytics and AI-driven interoperability platforms 86 6.7.3.2 Digital health platforms, integration, and regulatory infrastructure 86 6.7.3.3 Clinical care, payer operations, and personalized healthcare delivery 87 6.7.4 USER READINESS AND IMPACT ASSESSMENT 87 6.7.4.1 User readiness 87 6.7.4.1.1 User A: Healthcare Providers (Hospitals, Clinics, Long-Term Care Centers, Other Providers) 87 6.7.4.1.2 User B: Healthcare Payers 87 6.7.4.2 Impact assessment 88 6.7.4.2.1 User A: Healthcare Providers 88 6.7.4.2.1.1 Implementation 88 6.7.4.2.1.2 Impact 88 6.7.4.2.2 User B: Healthcare Payers 88 6.7.4.2.2.1 Implementation 88 6.7.4.2.2.2 Impact 88 7 REGULATORY LANDSCAPE 89 7.1 REGIONAL REGULATIONS AND COMPLIANCE 89 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 7.1.2 INDUSTRY STANDARDS 92 8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 93 8.1 DECISION-MAKING PROCESS 93 8.2 KEY STAKEHOLDERS IN BUYING PROCESS AND THEIR EVALUATION CRITERIA 93 8.2.1 KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS 94 8.2.2 BUYING CRITERIA 95 8.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES 96 8.4 UNMET NEEDS FROM END-USE INDUSTRIES 96 8.4.1 UNMET NEEDS 96 8.4.2 END-USER EXPECTATIONS 97 8.5 MARKET PROFITABILITY 98 9 HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION 99 9.1 INTRODUCTION 100 9.2 WEB PORTAL DEVELOPMENT 100 9.2.1 LARGE NUMBER OF PHYSICIANS OPTING FOR ELECTRONIC MEDICAL RECORDS TO DRIVE MARKET 100 9.3 WORKFLOW MANAGEMENT 102 9.3.1 BETTER DECISION-MAKING FOR ENHANCED PATIENT CARE TO PROPEL MARKET 102 9.4 SECURE MESSAGING 103 9.4.1 ABILITY TO PROVIDE SECURE COMMUNICATION WITHIN AND OUTSIDE CARE NETWORK TO SUPPORT MARKET GROWTH 103 9.5 INTERNAL INTERFACING 105 9.5.1 FASTEST-GROWING APPLICATION SEGMENT DURING FORECAST PERIOD 105 9.6 TRANSACTION MONITORING 106 9.6.1 SECURE, EFFICIENT, AND COMPLIANT EXCHANGE OF HEALTH DATA—KEY FACTORS DRIVING MARKET GROWTH 106   10 HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT 108 10.1 INTRODUCTION 109 10.2 CLINICAL DATA REPOSITORY 109 10.2.1 EASY ACCESS TO DATA ACROSS EMR DOMAIN TO SUPPORT MARKET GROWTH 109 10.3 ENTERPRISE MASTER PERSON INDEX 110 10.3.1 EMPI TO DOMINATE HIE MARKET DURING FORECAST PERIOD 110 10.4 RECORD LOCATOR SERVICE 112 10.4.1 RLS TO REGISTER HIGHEST GROWTH RATE 112 10.5 HEALTHCARE PROVIDER DIRECTORY 113 10.5.1 COMPREHENSIVE DATABASE AND RELIABILITY OF HPD TO DRIVE MARKET 113 11 HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL 114 11.1 INTRODUCTION 115 11.2 HYBRID MODEL 115 11.2.1 HYBRID HIE MODELS TO HOLD LARGEST MARKET SHARE 115 11.3 CENTRALIZED MODEL 117 11.3.1 PRIVACY AND SECURITY CONCERNS TO HINDER ADOPTION OF CENTRALIZED HIE 117 11.4 DECENTRALIZED/FEDERATED 118 11.4.1 REAL-TIME UPDATED DATA AVAILABILITY AND INCREASED SECURITY TO DRIVE ADOPTION 118 12 HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE 120 12.1 INTRODUCTION 121 12.2 PRIVATE 121 12.2.1 RISING MANDATES FOR INCENTIVE PROGRAMS TO DRIVE MARKET 121 12.3 PUBLIC 123 12.3.1 GROWING GOVERNMENT FUNDING TO SUPPORT MARKET GROWTH 123 13 HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION 126 13.1 INTRODUCTION 127 13.2 PORTAL-CENTRIC HIE SOLUTIONS 127 13.2.1 PORTAL-CENTRIC SOLUTIONS TO DOMINATE HEALTH INFORMATION EXCHANGE MARKET DURING FORECAST PERIOD 127 13.3 MESSAGING-CENTRIC HIE SOLUTIONS 128 13.3.1 HIGH PERFORMANCE AND RELIABILITY OF MESSAGING-CENTRIC SOLUTIONS TO DRIVE MARKET 128 13.4 PLATFORM-CENTRIC HIE SOLUTIONS 129 13.4.1 PLATFORM-CENTRIC SOLUTIONS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 129   14 HEALTH INFORMATION EXCHANGE MARKET, BY TYPE 131 14.1 INTRODUCTION 132 14.2 DIRECTED EXCHANGE 132 14.2.1 DIRECTED EXCHANGE SEGMENT TO COMMAND LARGEST SHARE OF HEALTH INFORMATION EXCHANGE MARKET 132 14.3 QUERY-BASED EXCHANGE 134 14.3.1 QUERY-BASED EXCHANGE SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 134 14.4 CONSUMER-MEDIATED EXCHANGE 135 14.4.1 GROWING PATIENT-PHYSICIAN INTERACTION TO DRIVE POPULARITY OF CONSUMER-MEDIATED SOLUTIONS 135 15 HEALTH INFORMATION EXCHANGE MARKET, BY REGION 137 15.1 INTRODUCTION 138 15.2 NORTH AMERICA 138 15.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 139 15.2.2 US 144 15.2.2.1 Layered interoperability and stringent certification requirements to drive market 144 15.2.3 CANADA 148 15.2.3.1 Government initiatives to support HIE adoption in Canada 148 15.3 EUROPE 152 15.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 153 15.3.2 GERMANY 157 15.3.2.1 Landmark Health Data Use Act and EHDS alignment catalyze research-grade HIE platforms 157 15.3.3 UK 161 15.3.3.1 Growing patient volumes to drive market 161 15.3.4 FRANCE 165 15.3.4.1 Favorable government initiatives to drive market 165 15.3.5 ITALY 169 15.3.5.1 PNRR-funded FSE 2.0 drives national interoperability and cross-regional HIE unification 169 15.3.6 SPAIN 174 15.3.6.1 Cross-regional HIE scale-up and national AI strategy cement digital health leadership 174 15.3.7 REST OF EUROPE 177 15.4 ASIA PACIFIC 181 15.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 182 15.4.2 JAPAN 187 15.4.2.1 Growing need to digitize patient records to drive market 187 15.4.3 CHINA 191 15.4.3.1 Large patient population and healthcare infrastructure improvements to drive market 191 15.4.4 INDIA 195 15.4.4.1 Rising need for cost-effective technologies to drive HCIT integration in India 195 15.4.5 REST OF ASIA PACIFIC 200 15.5 LATIN AMERICA 204 15.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 204 15.5.2 BRAZIL 208 15.5.2.1 RNDS formalized as national interoperability backbone with 2.8 billion clinical records 208 15.5.3 MEXICO 213 15.5.3.1 openEHR Adoption and IMSS digital health modernization drive national HIE platform investment 213 15.5.4 REST OF LATIN AMERICA 216 15.6 MIDDLE EAST & AFRICA 220 15.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 221 15.6.2 GCC COUNTRIES 224 15.6.2.1 Growing focus on implementing HCIT to drive market 224 15.6.3 REST OF MIDDLE EAST & AFRICA 228 16 COMPETITIVE LANDSCAPE 233 16.1 OVERVIEW 233 16.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2023–2026 233 16.3 REVENUE ANALYSIS, 2021–2025 235 16.4 MARKET SHARE ANALYSIS, 2025 236 16.5 BRAND/SOFTWARE COMPARISON 239 16.6 COMPANY VALUATION & FINANCIAL METRICS 240 16.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 241 16.7.1 STARS 241 16.7.2 EMERGING LEADERS 241 16.7.3 PERVASIVE PLAYERS 241 16.7.4 PARTICIPANTS 241 16.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 243 16.7.5.1 Company footprint 243 16.7.5.2 Region footprint 244 16.7.5.3 Setup type footprint 245 16.7.5.4 End user footprint 246 16.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 247 16.8.1 PROGRESSIVE COMPANIES 247 16.8.2 RESPONSIVE COMPANIES 247 16.8.3 DYNAMIC COMPANIES 247 16.8.4 STARTING BLOCKS 247 16.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 249   16.9 COMPETITIVE SCENARIO 250 16.9.1 PRODUCT LAUNCHES 250 16.9.2 DEALS 251 17 COMPANY PROFILES 252 17.1 KEY PLAYERS 252 17.1.1 EPIC SYSTEMS CORPORATION. 252 17.1.1.1 Business overview 252 17.1.1.2 Products and Services offered 253 17.1.1.3 Recent developments 254 17.1.1.3.1 Product launches and approvals 254 17.1.1.3.2 Deals 254 17.1.1.4 MnM view 255 17.1.1.4.1 Right to win 255 17.1.1.4.2 Strategic choices 256 17.1.1.4.3 Weaknesses and competitive threats 256 17.1.2 ORACLE 257 17.1.2.1 Business overview 257 17.1.2.2 Products and services offered 258 17.1.2.3 Recent developments 259 17.1.2.3.1 Product launches and approvals 259 17.1.2.3.2 Deals 260 17.1.2.4 MnM view 261 17.1.2.4.1 Right to win 261 17.1.2.4.2 Strategic choices 261 17.1.2.4.3 Weaknesses and competitive threats 261 17.1.3 INTERSYSTEMS CORPORATION 263 17.1.3.1 Business overview 263 17.1.3.2 Products and services offered 264 17.1.3.3 Recent developments 265 17.1.3.3.1 Product launches and approvals 265 17.1.3.3.2 Deals 265 17.1.3.4 MnM view 265 17.1.3.4.1 Right to win 266 17.1.3.4.2 Strategic choices 266 17.1.3.4.3 Weaknesses and competitive threats 266 17.1.4 VERADIGM LLC 268 17.1.4.1 Business overview 268 17.1.4.2 Products and services offered 270 17.1.4.3 Recent developments 271 17.1.4.3.1 Product launches and approvals 271 17.1.4.3.2 Deals 271 17.1.4.4 MnM view 271 17.1.4.4.1 Right to win 271 17.1.4.4.2 Strategic choices 272 17.1.4.4.3 Weaknesses and competitive threats 272 17.1.5 MEDICAL INFORMATION TECHNOLOGY, INC. 273 17.1.5.1 Business overview 273 17.1.5.2 Products and services offered 274 17.1.5.3 Recent developments 275 17.1.5.3.1 Product launches and approvals 275 17.1.5.3.2 Deals 275 17.1.5.4 MnM view 276 17.1.5.4.1 Right to win 276 17.1.5.4.2 Strategic choices 276 17.1.5.4.3 Weaknesses and competitive threats 276 17.1.6 HEALTH CATALYST 278 17.1.6.1 Business overview 278 17.1.6.2 Products and services offered 280 17.1.6.3 Recent developments 280 17.1.6.3.1 Deals 280 17.1.7 KELLTON 282 17.1.7.1 Business overview 282 17.1.7.2 Products and services offered 283 17.1.7.3 Recent developments 284 17.1.7.3.1 Deal 284 17.1.8 ECLINICALWORKS 285 17.1.8.1 Business overview 285 17.1.8.2 Products and services offered 286 17.1.8.3 Recent developments 286 17.1.8.3.1 Product launches and approvals 286 17.1.8.3.2 Deal 287 17.1.9 NXGN MANAGEMENT, LLC. 288 17.1.9.1 Business overview 288 17.1.9.2 Products and services offered 288 17.1.10 ORION HEALTH GROUP OF COMPANIES 290 17.1.10.1 Business overview 290 17.1.10.2 Products and services offered 291 17.1.10.3 Recent developments 291 17.1.10.3.1 Deal 291 17.1.11 CHETU INC. 292 17.1.11.1 Business overview 292 17.1.11.2 Products and services offered 292 17.1.11.3 Recent developments 293 17.1.11.3.1 Deal 293 17.1.12 TELSTRA HEALTH (A SUBSIDIARY OF TELSTRA CORPORATION LTD.) 294 17.1.12.1 Business overview 294 17.1.12.2 Products and services offered 295 17.1.12.2.1 Deal 295 17.1.13 CGI INC. 296 17.1.13.1 Business overview 296 17.1.13.2 Products and services offered 297 17.1.13.3 Recent developments 298 17.1.13.3.1 Product launches and approvals 298 17.1.13.3.2 Deal 298 17.1.14 MEDITAB 299 17.1.14.1 Business overview 299 17.1.14.2 Products and services offered 300 17.1.15 DREAMSOFT4U 301 17.1.15.1 Business overview 301 17.1.15.2 Products and services offered 301 17.1.16 NCRYPTED TECHNOLOGIES 302 17.1.16.1 Business overview 302 17.1.16.2 Products and services offered 302 17.1.17 GLORIUM TECHNOLOGIES 303 17.1.17.1 Business overview 303 17.1.17.2 Products and services offered 303 17.1.18 DAFFODIL UNTHINKABLE SOFTWARE CORP. 305 17.1.18.1 Business overview 305 17.1.18.2 Products and services offered 306 17.1.19 SIEMENS HEALTHINEERS AG 307 17.1.19.1 Business overview 307 17.1.19.2 Products and services offered 308 17.1.19.2.1 Product launches and approvals 309 17.1.20 DELOITTE 311 17.1.20.1 Business overview 311 17.1.20.2 Products and services offered 312 17.1.20.3 Recent developments 312 17.1.20.3.1 Deals 312 17.1.21 EXCELICARE 313 17.1.21.1 Business overview 313 17.1.21.2 Products and services offered 314   17.2 OTHER PLAYERS 315 17.2.1 OCTAL IT SOLUTION 315 17.2.2 ANDERSEN INC. 316 17.2.3 SISGAIN 317 17.2.4 CLEVERDEV SOFTWARE 318 17.2.5 OSP LABS 319 18 RESEARCH METHODOLOGY 320 18.1 RESEARCH DATA 320 18.1.1 SECONDARY DATA 321 18.1.1.1 Key data from secondary sources 322 18.1.2 PRIMARY DATA 322 18.1.2.1 Key data from primary sources 324 18.1.2.2 Breakdown of primaries 324 18.1.2.3 Insights from primary experts 325 18.2 RESEARCH METHODOLOGY DESIGN 325 18.3 MARKET SIZE ESTIMATION 326 18.4 MARKET BREAKDOWN DATA TRIANGULATION 331 18.5 MARKET SHARE ESTIMATION 332 18.6 STUDY ASSUMPTIONS 332 18.7 RESEARCH LIMITATIONS 333 18.7.1 METHODOLOGY-RELATED LIMITATIONS 333 18.8 RISK ASSESSMENT 333 19 APPENDIX 334 19.1 DISCUSSION GUIDE 334 19.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 340 19.3 CUSTOMIZATION OPTIONS 342 19.4 RELATED REPORTS 342 19.5 AUTHOR DETAILS 343
圖表清單 List of Tables & Figures
TABLE 1 EXCHANGE RATES FOR CONVERSION TO USD 32 TABLE 2 IMPACT OF PORTER’S FIVE FORCES 57 TABLE 3 ROLE OF COMPANIES IN ECOSYSTEM 63 TABLE 4 INDICATIVE PRICES OF HEALTHCARE INFORMATION EXCHANGE MARKET, BY PRODUCT, 2025 64 TABLE 5 INDICATIVE PRICES OF HEALTHCARE INFORMATION EXCHANGE MARKET, BY REGION, 2025 65 TABLE 6 KEY CONFERENCES AND EVENTS, 2026–2027 66 TABLE 7 CASE 1: HEALTHINFONET, IN COLLABORATION WITH ORION HEALTH, ENSURES RAPID DELIVERY OF HIE SERVICES TO MAINE PATIENTS AND HEALTHCARE PROVIDERS 68 TABLE 8 CASE 2: WIRRAL SETS UP CERNER-BASED INFO SHARING 68 TABLE 9 CASE 3: HIE SOLUTIONS ENABLE WELLSPRING NURSES TO GATHER PATIENT INFORMATION TO ENSURE CONTINUITY AND QUALITY OF CARE 69 TABLE 10 US-ADJUSTED RECIPROCAL TARIFF RATES 70 TABLE 11 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR HEALTHCARE INFORMATION EXCHANGE MARKET 79 TABLE 12 HEALTHCARE INFORMATION EXCHANGE MARKET: LIST OF PATENTS/PATENT APPLICATIONS 80 TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 90 TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 91 TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 94 TABLE 19 KEY BUYING CRITERIA, BY END USER 95 TABLE 20 UNMET NEEDS IN HEALTHCARE INFORMATION EXCHANGE MARKET 97 TABLE 21 END-USER EXPECTATIONS IN HEALTHCARE INFORMATION EXCHANGE PHARMA & BIOTECH MARKET 97 TABLE 22 HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 100 TABLE 23 HEALTH INFORMATION EXCHANGE MARKET FOR WEB PORTAL DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 101 TABLE 24 EXAMPLES OF SOLUTIONS FOR WORKFLOW MANAGEMENT 102 TABLE 25 HEALTH INFORMATION EXCHANGE MARKET FOR WORKFLOW MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 103 TABLE 26 HEALTH INFORMATION EXCHANGE MARKET FOR SECURE MESSAGING, BY COUNTRY, 2024–2031 (USD MILLION) 105 TABLE 27 HEALTH INFORMATION EXCHANGE MARKET FOR INTERNAL INTERFACING, BY COUNTRY, 2024–2031 (USD MILLION) 106 TABLE 28 HEALTH INFORMATION EXCHANGE MARKET FOR TRANSACTION MONITORING, BY COUNTRY, 2024–2031 (USD MILLION) 107 TABLE 29 HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 109 TABLE 30 HEALTH INFORMATION EXCHANGE MARKET FOR CLINICAL DATA REPOSITORY, BY COUNTRY, 2024–2031 (USD MILLION) 110 TABLE 31 HEALTH INFORMATION EXCHANGE MARKET FOR ENTERPRISE MASTER PERSON INDEX, BY COUNTRY, 2024–2031 (USD MILLION) 111 TABLE 32 HEALTH INFORMATION EXCHANGE MARKET FOR RECORD LOCATOR SERVICE, BY COUNTRY, 2024–2031 (USD MILLION) 112 TABLE 33 HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDER DIRECTORY, BY COUNTRY, 2024–2031 (USD MILLION) 113 TABLE 34 HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 115 TABLE 35 HYBRID HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 116 TABLE 36 CENTRALIZED HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 118 TABLE 37 DECENTRALIZED/FEDERATED HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 119 TABLE 38 HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 121 TABLE 39 PRIVATE SETUP OFFERED BY MARKET PLAYERS 122 TABLE 40 PRIVATE HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 123 TABLE 41 PUBLIC SETUP OFFERED BY MARKET PLAYERS 124 TABLE 42 PUBLIC HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 125 TABLE 43 HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 127 TABLE 44 PORTAL-CENTRIC HIE SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 128 TABLE 45 MESSAGING-CENTRIC HIE SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 46 PLATFORM-CENTRIC HIE SOLUTIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 47 HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 132 TABLE 48 DIRECTED HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 49 QUERY-BASED HEALTHCARE INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 50 CONSUMER-MEDIATED HIE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 51 HEALTH INFORMATION EXCHANGE MARKET, BY REGION, 2024–2031 (USD MILLION) 138 TABLE 52 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 53 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 140 TABLE 54 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 140 TABLE 55 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 141 TABLE 56 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 141 TABLE 57 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 142 TABLE 58 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 142 TABLE 59 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 143 TABLE 60 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 143 TABLE 61 US: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 145 TABLE 62 US: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 145 TABLE 63 US: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 146 TABLE 64 US: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 146 TABLE 65 US: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 147 TABLE 66 US: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 147 TABLE 67 US: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 148 TABLE 68 US: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 148 TABLE 69 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 149 TABLE 70 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 150 TABLE 71 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 150 TABLE 72 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 150 TABLE 73 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 151 TABLE 74 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 151 TABLE 75 CANADA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 152 TABLE 76 CANADA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 152 TABLE 77 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 78 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 154 TABLE 79 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 154 TABLE 80 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 154 TABLE 81 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 155 TABLE 82 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 155 TABLE 83 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 156 TABLE 84 EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 156 TABLE 85 INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 157 TABLE 86 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 158 TABLE 87 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 158 TABLE 88 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 158 TABLE 89 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 159 TABLE 90 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 159 TABLE 91 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 160 TABLE 92 GERMANY: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 160 TABLE 93 GERMANY: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 161 TABLE 94 UK: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 162 TABLE 95 UK: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 162 TABLE 96 UK: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 162 TABLE 97 UK: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 163 TABLE 98 UK: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 163 TABLE 99 UK: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 164 TABLE 100 UK: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 164 TABLE 101 UK: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 165 TABLE 102 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 166 TABLE 103 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 166 TABLE 104 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 167 TABLE 105 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 167 TABLE 106 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 168 TABLE 107 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 168 TABLE 108 FRANCE: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 169 TABLE 109 FRANCE: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 169 TABLE 110 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 170 TABLE 111 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 170 TABLE 112 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 171 TABLE 113 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 171 TABLE 114 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 172 TABLE 115 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 172 TABLE 116 ITALY: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 173 TABLE 117 ITALY: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 173 TABLE 118 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 174 TABLE 119 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 175 TABLE 120 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 175 TABLE 121 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 175 TABLE 122 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 176 TABLE 123 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 176 TABLE 124 SPAIN: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 177 TABLE 125 SPAIN: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 177 TABLE 126 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 178 TABLE 127 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 179 TABLE 128 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 179 TABLE 129 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 179 TABLE 130 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 180 TABLE 131 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 180 TABLE 132 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 181 TABLE 133 REST OF EUROPE: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 181 TABLE 134 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 135 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 184 TABLE 136 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 184 TABLE 137 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 184 TABLE 138 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 185 TABLE 139 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 185 TABLE 140 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 186 TABLE 141 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 186 TABLE 142 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 187 TABLE 143 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 188 TABLE 144 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 188 TABLE 145 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 189 TABLE 146 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 189 TABLE 147 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 190 TABLE 148 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 190 TABLE 149 JAPAN: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 191 TABLE 150 JAPAN: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 191 TABLE 151 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 192 TABLE 152 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 193 TABLE 153 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 193 TABLE 154 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 193 TABLE 155 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 194 TABLE 156 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 194 TABLE 157 CHINA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 195 TABLE 158 CHINA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 195 TABLE 159 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 196 TABLE 160 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 196 TABLE 161 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 197 TABLE 162 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 198 TABLE 163 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 198 TABLE 164 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 199 TABLE 165 INDIA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 199 TABLE 166 INDIA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 200 TABLE 167 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 201 TABLE 168 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 201 TABLE 169 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 201 TABLE 170 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 202 TABLE 171 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 202 TABLE 172 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 203 TABLE 173 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 203 TABLE 174 REST OF ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 204 TABLE 175 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 176 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 205 TABLE 177 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 205 TABLE 178 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 206 TABLE 179 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 206 TABLE 180 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 207 TABLE 181 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 207 TABLE 182 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 208 TABLE 183 LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 184 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 185 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 210 TABLE 186 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 210 TABLE 187 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 210 TABLE 188 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 211 TABLE 189 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 211 TABLE 190 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 212 TABLE 191 BRAZIL: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 192 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 193 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 214 TABLE 194 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 214 TABLE 195 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 214 TABLE 196 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 215 TABLE 197 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 215 TABLE 198 MEXICO: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 216 TABLE 199 MEXICO: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 216 TABLE 200 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 201 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 217 TABLE 202 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 218 TABLE 203 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 218 TABLE 204 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 219 TABLE 205 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 219 TABLE 206 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 220 TABLE 207 REST OF LATIN AMERICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 208 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 209 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 210 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 222 TABLE 211 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 222 TABLE 212 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 222 TABLE 213 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 223 TABLE 214 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 223 TABLE 215 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 224 TABLE 216 MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 217 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 218 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 226 TABLE 219 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 226 TABLE 220 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 226 TABLE 221 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 227 TABLE 222 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 227 TABLE 223 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 228 TABLE 224 GCC COUNTRIES: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 228 TABLE 225 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY TYPE, 2024–2031 (USD MILLION) 229 TABLE 226 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY SETUP TYPE, 2024–2031 (USD MILLION) 230 TABLE 227 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY IMPLEMENTATION MODEL, 2024–2031 (USD MILLION) 230 TABLE 228 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY SOLUTION, 2024–2031 (USD MILLION) 230 TABLE 229 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 231 TABLE 230 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 231 TABLE 231 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET, BY END USER, 2024–2031 (USD MILLION) 232 TABLE 232 REST OF MIDDLE EAST & AFRICA: HEALTH INFORMATION EXCHANGE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 232 TABLE 233 STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE INFORMATION EXCHANGE MARKET, JANUARY 2023–MAY 2026 233 TABLE 234 HEALTHCARE INFORMATION EXCHANGE MARKET: DEGREE OF COMPETITION 237 TABLE 235 HEALTH INFORMATION EXCHANGE MARKET: REGION FOOTPRINT 244 TABLE 236 HEALTH INFORMATION EXCHANGE MARKET: SETUP TYPE FOOTPRINT 245 TABLE 237 HEALTH INFORMATION EXCHANGE MARKET: END USER FOOTPRINT 246 TABLE 238 HEALTH INFORMATION EXCHANGE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 249 TABLE 239 HEALTH INFORMATION EXCHANGE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 250 TABLE 240 HEALTH INFORMATION EXCHANGE MARKET: PRODUCT LAUNCHES, JANUARY 2023–MAY 2026 250 TABLE 241 HEALTH INFORMATION EXCHANGE MARKET: DEALS, JANUARY 2023–MAY 2026 251 TABLE 242 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW 253 TABLE 243 EPIC SYSTEMS CORPORATION: PRODUCTS OFFERED 253 TABLE 244 EPIC SYSTEMS CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 254 TABLE 245 EPIC SYSTEMS CORPORATION: DEALS, JANUARY 2023–MAY 2026 254 TABLE 246 ORACLE: BUSINESS OVERVIEW 257 TABLE 247 ORACLE: PRODUCTS OFFERED 258 TABLE 248 ORACLE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 259 TABLE 249 ORACLE: DEALS, JANUARY 2022–MAY 2026 260 TABLE 250 INTERSYSTEMS CORPORATION: BUSINESS OVERVIEW 264 TABLE 251 INTERSYSTEMS CORPORATION: PRODUCTS OFFERED 264 TABLE 252 INTERSYSTEMS CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 265 TABLE 253 INTERSYSTEMS CORPORATION: DEALS, JANUARY 2022–MAY 2026 265 TABLE 254 VERADIGM LLC: BUSINESS OVERVIEW 269 TABLE 255 VERADIGM LLC: PRODUCTS OFFERED 270 TABLE 256 VERADIGM LLC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 271 TABLE 257 VERADIGM LLC: DEALS, JANUARY 2022–MAY 2026 271 TABLE 258 MEDICAL INFORMATION TECHNOLOGY, INC.: BUSINESS OVERVIEW 274 TABLE 259 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS OFFERED 274 TABLE 260 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 275 TABLE 261 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS, JANUARY 2022–MAY 2026 275 TABLE 262 HEALTH CATALYST: BUSINESS OVERVIEW 279 TABLE 263 HEALTH CATALYST: PRODUCTS OFFERED 280 TABLE 264 HEALTH CATALYST: DEALS, JANUARY 2023–MAY 2026 280 TABLE 265 KELLTON: BUSINESS OVERVIEW 282 TABLE 266 KELLTON: PRODUCTS OFFERED 283 TABLE 267 KELLTON: DEALS, JANUARY 2023–MAY 2026 284 TABLE 268 ECLINICALWORKS: BUSINESS OVERVIEW 285 TABLE 269 ECLINICALWORKS: PRODUCTS OFFERED 286 TABLE 270 ECLINICALWORKS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 286 TABLE 271 ECLINICALWORKS: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 287 TABLE 272 NXGN MANAGEMENT, LLC. : BUSINESS OVERVIEW 288 TABLE 273 NXGN MANAGEMENT, LLC.: PRODUCTS OFFERED 288 TABLE 274 ORION HEALTH GROUP OF COMPANIES: BUSINESS OVERVIEW 290 TABLE 275 ORION HEALTH GROUP OF COMPANIES: PRODUCTS OFFERED 291 TABLE 276 ORION HEALTH GROUP OF COMPANIES: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 291 TABLE 277 CHETU INC.: BUSINESS OVERVIEW 292 TABLE 278 CHETU INC.: PRODUCTS OFFERED 292 TABLE 279 CHETU INC.: DEALS, JANUARY 2023–MAY 2026 293 TABLE 280 TELSTRA HEALTH: BUSINESS OVERVIEW 294 TABLE 281 TELSTRA HEALTH: PRODUCTS OFFERED 295 TABLE 282 TELSTRA HEALTH: DEALS, JANUARY 2023–MAY 2026 295 TABLE 283 CGI INC.: BUSINESS OVERVIEW 296 TABLE 284 CGI INC.: PRODUCTS OFFERED 297 TABLE 285 CGI INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 298 TABLE 286 CGI INC.: OTHER DEVELOPMENTS, JANUARY 2023–MAY 2026 298 TABLE 287 MEDITAB: BUSINESS OVERVIEW 299 TABLE 288 MEDITAB: PRODUCTS OFFERED 300 TABLE 289 DREAMSOFT4U: BUSINESS OVERVIEW 301 TABLE 290 DREAMSOFT4U: PRODUCTS OFFERED 301 TABLE 291 NCRYPTED TECHNOLOGIES.: BUSINESS OVERVIEW 302 TABLE 292 NCRYPTED TECHNOLOGIES: PRODUCTS OFFERED 302 TABLE 293 GLORIUM TECHNOLOGIES: BUSINESS OVERVIEW 303 TABLE 294 GLORIUM TECHNOLOGIES: PRODUCTS OFFERED 303 TABLE 295 DAFFODIL UNTHINKABLE SOFTWARE CORP.: BUSINESS OVERVIEW 305 TABLE 296 DAFFODIL UNTHINKABLE SOFTWARE CORP.: PRODUCTS AND SERVICES OFFERED 306 TABLE 297 SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW 307 TABLE 298 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED 308 TABLE 299 SIEMENS HEALTHINEERS AG: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2023–MAY 2026 309 TABLE 300 DELOITTE: BUSINESS OVERVIEW 311 TABLE 301 DELOITTE: PRODUCTS OFFERED 312 TABLE 302 DELOITTE: DEALS, JANUARY 2022–MAY 2026 312 TABLE 303 EXCELICARE: BUSINESS OVERVIEW 313 TABLE 304 EXCELICARE: PRODUCTS OFFERED 314 TABLE 305 RISK ASSESSMENT: HEALTHCARE INFORMATION EXCHANGE (HIE) MARKET 333 FIGURE 1 MARKET SCENARIO 34 FIGURE 2 GLOBAL HEALTHCARE INFORMATION EXCHANGE MARKET, 2024–2031 35 FIGURE 3 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE INFORMATION EXCHANGE MARKET 35 FIGURE 4 DISRUPTIONS INFLUENCING GROWTH OF HEALTHCARE INFORMATION EXCHANGE MARKET 36 FIGURE 5 HIGH-GROWTH SEGMENTS IN HEALTHCARE INFORMATION EXCHANGE MARKET 37 FIGURE 6 ASIA PACIFIC TO BE FASTEST-GROWING REGION DURING FORECAST PERIOD 38 FIGURE 7 EXPANSION OF INTEROPERABLE DIGITAL HEALTH ECOSYSTEMS AND REAL-TIME CLINICAL DATA EXCHANGE FUEL DEMAND 39 FIGURE 8 HEALTHCARE PROVIDERS AND US ACCOUNTED FOR LARGEST SHARE IN 2025 40 FIGURE 9 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 41 FIGURE 10 US: NUMBER OF DATA COMPROMISES (2021–2025) 51 FIGURE 11 PORTER’S FIVE FORCES ANALYSIS 56 FIGURE 12 HEALTH INFORMATION EXCHANGE MARKET VALUE CHAIN ANALYSIS (2025) 60 FIGURE 13 ECOSYSTEM ANALYSIS 62 FIGURE 14 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 67 FIGURE 16 PATENT PUBLICATION TRENDS IN HEALTHCARE INFORMATION EXCHANGE MARKET, 2015–2026 78 FIGURE 17 JURISDICTION AND TOP APPLICANT ANALYSIS FOR HEALTHCARE INFORMATION EXCHANGE MARKET 78 FIGURE 18 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE INFORMATION EXCHANGE MARKET (JANUARY 2015 TO FEBRUARY 2026) 79 FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 94 FIGURE 20 KEY BUYING CRITERIA, BY END USER 95 FIGURE 21 NORTH AMERICA: HEALTH INFORMATION EXCHANGE MARKET SNAPSHOT 139 FIGURE 22 ASIA PACIFIC: HEALTH INFORMATION EXCHANGE MARKET SNAPSHOT 183 FIGURE 23 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTH INFORMATION EXCHANGE MARKET (2021–2025) 235 FIGURE 24 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2025 236 FIGURE 25 HEALTH INFORMATION EXCHANGE MARKET: BRAND/SOFTWARE COMPARATIVE ANALYSIS 239 FIGURE 26 EV/EBITDA OF KEY VENDORS 240 FIGURE 27 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 240 FIGURE 28 HEALTH INFORMATION EXCHANGE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 242 FIGURE 29 HEALTH INFORMATION EXCHANGE MARKET: COMPANY FOOTPRINT 243 FIGURE 30 HEALTH INFORMATION EXCHANGE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 248 FIGURE 31 ORACLE: COMPANY SNAPSHOT (2024) 258 FIGURE 32 VERADIGM LLC: COMPANY SNAPSHOT (2022) 269 FIGURE 33 HEALTH CATALYST: COMPANY SNAPSHOT (2025) 279 FIGURE 34 KELLTON: COMPANY SNAPSHOT (2025) 283 FIGURE 35 CGI INC.: COMPANY SNAPSHOT (2025) 297 FIGURE 36 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2025) 308 FIGURE 37 RESEARCH DESIGN 320 FIGURE 38 PRIMARY SOURCES 323 FIGURE 39 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 324 FIGURE 40 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 326 FIGURE 41 BOTTOM-UP APPROACH 327 FIGURE 42 TOP-DOWN APPROACH 328 FIGURE 43 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DYNAMICS OF HEALTHCARE INFORMATION EXCHANGE 329 FIGURE 44 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 329 FIGURE 45 DATA TRIANGULATION METHODOLOGY 331

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們